However, a significant change in hepatic Shp expression was not observed, which suggested that hepatic Fxr might not account for the increased expression of Cyp7a1 and Cyp7b1 noted in APS-treated mice. The gene discussed is CYP7A1; the disease is autoimmune polyendocrinopathy.